Replies to post #198082 on NorthWest Biotherapeutics Inc (NWBO)

[Virgilio]

Yes, it seems good news, let's hope for the best.

[marzan]

yes flipper et al, thanks for walking us with you day and night, we hit the jackpot now. 28.2% OS for 3yrs is unseen before. Sojo's BB channel is broken upward for a reason into new highs starting Monday, imo. Luckily there are no call options sold out here in millions that no AMRN kind of hack job can be cooked this weekend. No escape route possible for naked shorts. Chapter Closed!

[skitahoe]

Is this a summary number for all patients in the trial? If so, the last patients to enroll in the trial really moved the bar substantially. Such a movement caused by 31 people out of over 300 might suggest that nearly all of them are still alive.

As I see it, Dr. Liau didn't unblind the trial to say this as no differentiation is being made between those on the drug, and those in the control group, but once unblinded, where the control can be differentiated from those who received the drug initially, as well as those who crossed over, the number should grow substantially more.

If I'm incorrect, and this is purely a look at the last patients, it's still significant, but I believe the number being cited would be for the entire trial, which remains blinded.

Gary

[sentiment_stocks]

approx. 93 total patients should live to 36 months or 28% (not 27%) of the trial’s enrollment.

Weird, huh? It does seem from our i-hub chart work (you, lykiri, meirluc, me, and several others), that my chicken scratchings of the monthly attrition rates (and subsequent discussions of it) based on that chart were very close to correct.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143791138&txt2find=LTFU

As were Brian Wells' numbers in his blog,
"Recently Released Interim Data On Northwest Biotherapeutics' DCVax-L Hints Of An Upcoming Blockbuster Cancer Treatment In Glioblastoma"

22.4 + 5.7 = 28.1% blended 36 month OS (as predicted)

https://seekingalpha.com/instablog/49123839-bwells18/5234734-recently-released-interim-data-northwest-biotherapeutics-dcvax-l-hints-upcoming-blockbuster

[VuBru]

Nice news, but it also means they have no incentive to unblind early.